During the past decade, Lucas Research, Inc. conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 4 clinical trials were completed, i.e. on average, 12.9% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 4 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lucas Research, Inc." #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "ModernaTX, Inc." with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Arrowhead Pharmaceuticals" with 2 trials sponsored and "Sagimet Biosciences Inc." with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lucas Research, Inc." #1 collaborator was "Integrium" with 1 trials as a collaborator, "Jaeb Center for Health Research" with 1 trials as a collaborator, "Mylan GmbH" with 1 trials as a collaborator and "Novo Nordisk A/S" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Lucas Research, Inc." are "NASH - Nonalcoholic Steatohepatitis" (4 trials), "Diabetes Mellitus, Type 2" (3 trials), "Diabetes Mellitus, Type 1" (2 trials), "Seasonal Influenza" (2 trials) and "Type 2 Diabetes" (2 trials). Many other conditions were trialed in "Lucas Research, Inc." in a lesser frequency.

Most popular intervention types in "Lucas Research, Inc." are "Drug" (24 trials), "Biological" (6 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "BI 456906" (3 trials), "Active Comparator" (2 trials), "Insulin Degludec" (2 trials) and "TVB-2640" (2 trials). Other intervention names were less common.

The vast majority of trials in "Lucas Research, Inc." are 30 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Lucas Research, Inc.". undefined are not yet recruiting, 13 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Lucas Research, Inc., 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lucas Research, Inc., 4 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".